Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome (PCOS) is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

Basics

Description

  • Polycystic ovarian syndrome (PCOS) is a common endocrine disorder with heterogeneous manifestations that affects 6–10% of the U.S. population.
  • Characterized by hyperandrogenism, insulin resistance, and anovulation, typically presenting as amenorrhea or oligomenorrhea
  • Diagnostic clinical characteristics include menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome.
  • The ovaries are often polycystic on imaging.
  • The etiology of PCOS is unknown, but presentation and course can be modified by lifestyle factors.
  • System(s) affected: reproductive, endocrine/metabolic, skin/exocrine
  • Synonym(s): Stein-Leventhal syndrome; polycystic ovary disease
ALERT
  • Condition may begin at puberty.
  • Obesity may amplify PCOS, but it is not diagnostic.
  • 20% of women with PCOS are not obese.
  • Predisposes to and is associated with obesity, hypertension, diabetes, metabolic syndrome, hyperlipidemia, infertility, insulin-resistance syndrome, endometrial hyperplasia, and uterine cancer

Epidemiology

Incidence
Incidence and prevalence are still highly debated due to a wide spectrum of diagnostic features; the National Institutes of Health (NIH) criteria require chronic anovulation and hyperandrogenism.

Prevalence

  • The prevalence based on NIH criteria is 7% of reproductive age women.
  • Predominant age: reproductive age
  • Predominant sex: females only

Etiology and Pathophysiology

  • Recent evidence points to a primary role for insulin resistance with hyperinsulinemia.
  • Increased GnRH pulsations in the hypothalamus lead to increased production of LH with limited production of FSH.
  • Hyperandrogenism: Ovaries are the main source of excess androgens (75% of circulating testosterone originates in the ovary). Polycystic ovaries have thickened thecal layers and overexpressed LH receptors, which cause excess androgen secretion.
  • Ovarian follicles: Abnormal androgen signaling may account for abnormal folliculogenesis causing polycystic ovaries.
  • Obesity results in compensatory hyperinsulinemia: Women with PCOS have insulin resistance similar to that in type 2 diabetes. Elevated levels of insulin decrease sex hormone–binding globulin (SHBG), increasing bioavailability of testosterone. Insulin may also act directly on adrenal glands, ovaries, and hypothalamus to enhance androgen production.
  • Insulin resistance causes elevated insulin levels and the frequently associated metabolic syndrome or frank diabetes mellitus.

Genetics

  • Likely a combination of polygenic and environmental factors
  • Implicated genes include DENND1A and THADA.

Risk Factors

See “Commonly Associated Conditions”; cause and effect are difficult to extricate in this disorder.

General Prevention

None known; focus on early diagnosis and treatment to prevent long-term complications.

Commonly Associated Conditions

  • Infertility
  • Obesity
  • Obstructive sleep apnea
  • Hypertension
  • Diabetes mellitus
  • Endometrial hyperplasia/carcinoma
  • Fatty liver disease
  • Mood disturbances and depression
  • Hirsutism

-- To view the remaining sections of this topic, please or --

Basics

Description

  • Polycystic ovarian syndrome (PCOS) is a common endocrine disorder with heterogeneous manifestations that affects 6–10% of the U.S. population.
  • Characterized by hyperandrogenism, insulin resistance, and anovulation, typically presenting as amenorrhea or oligomenorrhea
  • Diagnostic clinical characteristics include menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome.
  • The ovaries are often polycystic on imaging.
  • The etiology of PCOS is unknown, but presentation and course can be modified by lifestyle factors.
  • System(s) affected: reproductive, endocrine/metabolic, skin/exocrine
  • Synonym(s): Stein-Leventhal syndrome; polycystic ovary disease
ALERT
  • Condition may begin at puberty.
  • Obesity may amplify PCOS, but it is not diagnostic.
  • 20% of women with PCOS are not obese.
  • Predisposes to and is associated with obesity, hypertension, diabetes, metabolic syndrome, hyperlipidemia, infertility, insulin-resistance syndrome, endometrial hyperplasia, and uterine cancer

Epidemiology

Incidence
Incidence and prevalence are still highly debated due to a wide spectrum of diagnostic features; the National Institutes of Health (NIH) criteria require chronic anovulation and hyperandrogenism.

Prevalence

  • The prevalence based on NIH criteria is 7% of reproductive age women.
  • Predominant age: reproductive age
  • Predominant sex: females only

Etiology and Pathophysiology

  • Recent evidence points to a primary role for insulin resistance with hyperinsulinemia.
  • Increased GnRH pulsations in the hypothalamus lead to increased production of LH with limited production of FSH.
  • Hyperandrogenism: Ovaries are the main source of excess androgens (75% of circulating testosterone originates in the ovary). Polycystic ovaries have thickened thecal layers and overexpressed LH receptors, which cause excess androgen secretion.
  • Ovarian follicles: Abnormal androgen signaling may account for abnormal folliculogenesis causing polycystic ovaries.
  • Obesity results in compensatory hyperinsulinemia: Women with PCOS have insulin resistance similar to that in type 2 diabetes. Elevated levels of insulin decrease sex hormone–binding globulin (SHBG), increasing bioavailability of testosterone. Insulin may also act directly on adrenal glands, ovaries, and hypothalamus to enhance androgen production.
  • Insulin resistance causes elevated insulin levels and the frequently associated metabolic syndrome or frank diabetes mellitus.

Genetics

  • Likely a combination of polygenic and environmental factors
  • Implicated genes include DENND1A and THADA.

Risk Factors

See “Commonly Associated Conditions”; cause and effect are difficult to extricate in this disorder.

General Prevention

None known; focus on early diagnosis and treatment to prevent long-term complications.

Commonly Associated Conditions

  • Infertility
  • Obesity
  • Obstructive sleep apnea
  • Hypertension
  • Diabetes mellitus
  • Endometrial hyperplasia/carcinoma
  • Fatty liver disease
  • Mood disturbances and depression
  • Hirsutism

There's more to see -- the rest of this topic is available only to subscribers.